Skip to main content
OpenTrials

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,310 public trials 520 recruiting studies
Refine in advanced search Browse all conditions

Recurrence trial results

Completed

Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma

NCT00070304

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
Locations
  • Lurleen Wallace Comprehensive Cancer at University of Alabama-Birmingham Birmingham, Alabama, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
  • Loma Linda University Cancer Institute at Loma Linda University Medical Center Loma Linda, California, United States
View all 123 locations
View Trial Details
Completed

Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated With the Epstein Barr Virus

NCT00006340

Conditions
Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +47 more
Locations
  • Methodist Cancer Center at Methodist Hospital Indianapolis, Indiana, United States
  • Cancer Research Center at Boston Medical Center Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Hopital Necker Paris, France
View Trial Details
Completed

Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma

NCT00006760

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Hodgkin Disease, +10 more
Locations
  • Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group Downey, California, United States
View all 114 locations
View Trial Details
Completed

Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma

NCT00723359

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Mount Sinai Medical Center New York, United States
View Trial Details
Completed

Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma

NCT00994500

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +90 more
Locations
  • Childrens Memorial Hospital Chicago, Illinois, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Columbia University Medical Center New York, United States
  • Children's Hospital of Pittsburgh of UPMC Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions